Research ExplorerResearch UnitsCenter for Oncology Publications

Center for Oncology

3551 - 3600 out of 4,319Page size: 50

Publications

  1. 2009

  2. HER-2 amplification is highly homogenous in gastric cancer.

    Marx, A., Tharun, L., Muth, J., Dancau, A. M., Simon, R., Yekebas, E. F., Kaifi, J., Mirlacher, M., Brümmendorf, T., Bokemeyer, C., Izbicki, J. R. & Sauter, G., 2009, In: HUM PATHOL. 40, 6, p. 769-777 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. HER-2/neu analysis in breast cancer bone metastases.

    Zustin, J., Boddin, K., Tsourlakis, M. C., Burandt, E. C., Mirlacher, M., Jänicke, F., Izbicki, J. R., Rüther, W., Rueger, J. M., Bokemeyer, C., Simon, R. & Sauter, G., 2009, In: J CLIN PATHOL. 62, 6, p. 542-546 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

    Mazzone, M., Dettori, D., Rodrigo, L. D. O., Loges, S., Schmidt, T., Jonckx, B., Tian, Y-M., Lanahan, A. A., Pollard, P., Carmen, R. D. A., Frederik, D. S., Vinckier, S., Aragonés, J., Debackere, K., Luttun, A., Wyns, S., Jordan, B., Pisacane, A., Gallez, B., Lampugnani, M. G., Dejana, E., Simons, M., Ratcliffe, P., Maxwell, P. & Carmeliet, P., 2009, In: CELL. 136, 5, p. 839-851 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

    Lorch, A., Neubauer, A., Hackenthal, M., Dieing, A., Hartmann, J. T., Rick, O., Bokemeyer, C. & Beyer, J., 2009, In: ANN ONCOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. High-dose chemotherapy in nonseminomatous germ cell cancer.

    Kollmannsberger, C., Beyer, J. & Bokemeyer, C., 2009, In: BJU INT. 104, 9, p. 1398-1403 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    Kröger, N., Zabelina, T., Binder, T., Ayuketang Ayuk, F., Bacher, U., Amtsfeld, G., Lellek, H., Schrum, J., Erttmann, R., Eiermann, T. & Zander, A. R., 2009, In: BIOL BLOOD MARROW TR. 15, 4, p. 454-462 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.

    Bock, O., Muth, M., Theophile, K., Winter, M., Hussein, K., Büsche, G., Kröger, N. & Kreipe, H., 2009, In: BRIT J HAEMATOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Impact of homologous recombination on individual cellular radiosensitivity.

    Koch, K., Wrona, A., Dikomey, E. & Borgmann, K., 2009, In: RADIOTHER ONCOL. 90, 2, p. 265-272 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. [Improving care in haemophilia treatment: development of a computerized registry]

    Holstein, K., Holstein, F., Bokemeyer, C. & Eifrig, B., 2009, In: HAMOSTASEOLOGIE. 29, 1, p. 27-28 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Interactive diagnostics in the indication to allogeneic SCT in AML.

    Bacher, U., Haferlach, C., Schnittger, S., Kern, W., Kröger, N., Zander, A. R. & Haferlach, T., 2009, In: BONE MARROW TRANSPL. 43, 10, p. 745-756 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

    Kobold, S., Hegewisch-Becker, S., Oechsle, K., Jordan, K., Bokemeyer, C. & Atanackovic, D., 2009, In: ONCOLOGIST. 14, 12, p. 1242-1251 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).

    Niebuhr, B., Iwanski, G., Schwieger, M., Roscher, S., Stocking, C. & Cammenga, J., 2009, In: LEUKEMIA. 23, 5, p. 978-983 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Isopathic treatment effects of Arsenicum album 45x on wheat seedling growth--further reproduction trials.

    Lahnstein, L., Binder, M., Thurneysen, A., Frei-Erb, M., Betti, L., Peruzzi, M., Heusser, P. & Baumgartner, S., 2009, In: HOMEOPATHY. 98, 4, p. 198-207 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

    Kröger, N., Alchalby, H., Klyuchnikov, E., Badbaran, A., Hildebrandt, Y., Ayuketang Ayuk, F., Bacher, U., Bock, O., Kvasnicka, M., Fehse, B. & Zander, A. R., 2009, In: BLOOD. 113, 8, p. 1866-1868 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Kardiotoxizitäten bei Chemo-Radiotherapie

    Oechsle, K. & Bokemeyer, C., 2009, In: ONKOLOGE. 15, p. 157-162

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Lapatinib

    Schneider-Merck, T. & Trepel, M., 2009, Small Molecules in Oncology: (Recent Results in Cancer Research). Springer Verl, p. 45-59 15 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  18. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

    Lioznov, M., El-Cheikh, J., Hoffmann, F., Hildebrandt, Y., Ayuketang Ayuk, F., Wolschke, C., Atanackovic, D., Schilling, G., Badbaran, A., Bacher, U., Fehse, B., Zander, A. R., Blaise, D., Mohty, M. & Kröger, N., 2009, In: BONE MARROW TRANSPL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis.

    Riecken, K., Mock, U., Petrowitz, B., Bartsch, U. & Fehse, B., 2009, In: GENE THER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

    Atanackovic, D., Luetkens, T., Hildebrandt, Y., Arfsten, J., Bartels, K., Horn, C., Stahl, T., Cao, Y., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: CLIN CANCER RES. 15, 4, p. 1343-1352 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta.

    Neijenhuis, S., Verwijs-Janssen, M., Kasten-Pisula, U., Rumping, G., Borgmann, K., Dikomey, E., Begg, A. C. & Vens, C., 2009, In: DNA REPAIR. 8, 3, p. 336-346 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

    Honecker, F., Wermann, H., Mayer, F., Gillis, A. J. M., Stoop, H., Gurp, V., Oechsle, K., Oechsle, K., Steyerberg, E., Hartmann, J. T., Dinjens, W. N. M., Bokemeyer, C., Bokemeyer, C. & Looijenga, L. H. J., 2009, In: J CLIN ONCOL. 27, 13, p. 2129-2136 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.

    Aapro, M., Ludwig, H., Bokemeyer, C., MacDonald, K., Soubeyran, P., Turner, M., Albrecht, T. & Abraham, I., 2009, In: ANN ONCOL. 20, 10, p. 1714-1721 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Molecular determinants of prognosis in acute myeloid leukemia (AML) with normal karyotype.

    Bacher, U. & Haferlach, C., 2009, In: LEUKEMIA LYMPHOMA. 50, 9, p. 1403-1405 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.

    Schittenhelm, M. M., Kollmannsberger, C., Oechsle, K., Harlow, A., Morich, J., Honecker, F., Kurek, R., Störkel, S., Kanz, L., Corless, C. L., Wong, K-K., Bokemeyer, C. & Heinrich, M. C., 2009, In: MOL CANCER THER. 8, 3, p. 481-489 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Molecular diagnostics in acute leukemias.

    Bacher, U., Schnittger, S., Haferlach, C. & Haferlach, T., 2009, In: CLIN CHEM LAB MED. 47, 11, p. 1333-1341 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.

    Friedrich, N., Haring, R., Nauck, M., Lüdemann, J., Rosskopf, D., Spilcke-Liss, E., Felix, S. B., Dörr, M., Brabant, G., Völzke, H. & Wallaschofski, H., 2009, In: J CLIN ENDOCR METAB. 94, 5, p. 1732-1739 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Neuroonkologie

    Kammler, G., Kordes, U., Hornung, D., LINHART, D. & Hagel, C., 2009, Neuropädiatrie - Evidenzbasierte Therapie. Elsevier, p. 215-239 25 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  29. Novel KRIT1 mutation and no molecular evidence of anticipation in a family with cerebral and spinal cavernous malformations.

    Kuhn, J., Brümmendorf, T., Brassat, U., Lehnhardt, F. G., Chung, B-D., Harnier, S., Bewermeyer, H., Harzheim, A., Assheuer, J. & Netzer, C., 2009, In: EUR NEUROL. 61, 3, p. 154-158 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.

    Gnjatic, S., Cao, Y., Reichelt, U., Yekebas, E. F., Nölker, C., Marx, A., Erbersdobler, A., Nishikawa, H., Hildebrandt, Y., Bartels, K., Horn, C., Stahl, T., Gout, I., Filonenko, V., Ling, K-L., Cerundolo, V., Luetkens, T., Ritter, G., Friedrichs, K., Leuwer, R., Hegewisch-Becker, S., Izbicki, J. R., Bokemeyer, C., Old, L. J. & Atanackovic, D., 2009, In: INT J CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT.

    Chevallier, P., Labopin, M., Nagler, A., Ljungman, P., Verdonck, L. F., Volin, L., Zander, A. R., Finke, J., Socie, G., Cordonnier, C., Harousseau, J-L., Mohty, M. & Rocha, V., 2009, In: BONE MARROW TRANSPL. 44, 9, p. 589-594 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Outcome of allo-SCT for chronic myelomonocytic leukemia.

    Ocheni, S., Kröger, N., Zabelina, T., Zander, A. R. & Bacher, U., 2009, In: BONE MARROW TRANSPL. 43, 8, p. 659-661 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Outcome of transplantation for myelofibrosis.

    Ballen, K. K., Shrestha, S., Sobocinski, K. A., Zhang, M-J., Bashey, A., Bolwell, B. J., Cervantes, F., Devine, S. M., Gale, R. P., Gupta, V., Hahn, T. E., Hogan, W. J., Kröger, N., Litzow, M. R., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Schiller, G., Harry, C. S., Roy, V., Wiernik, P. H., Horowitz, M. M., Giralt, S. A. & Arora, M., 2009, In: BIOL BLOOD MARROW TR. *16*, 3, p. 358-367 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.

    Choschzick, M., Lebeau, A., Marx, A., Tharun, L., Terracciano, L., Heilenkötter, U., Jänicke, F., Bokemeyer, C., Simon, R., Sauter, G. & Schwarz, J., 2009, In: HUM PATHOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Patient-specific finite element modeling of respiratory lung motion using 4D CT image data.

    Werner, R., Ehrhardt, J., Schmidt, R. & Handels, H., 2009, In: MED PHYS. 36, 5, p. 1500-1511 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    Ocheni, S., Zabelina, T., Bacher, U., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2009, In: LEUKEMIA LYMPHOMA. 50, 4, p. 612-618 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study.

    Krause, K., Jaquet, K., Schneider, C., Haupt, S., Lioznov, M., Otte, K-M. & Kuck, K-H., 2009, In: HEART. 95, 14, p. 1145-1152 14.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.

    Bacher, U., Kohlmann, A. & Haferlach, T., 2009, In: Brief Funct Genomic Proteomic. 8, 3, p. 184-193 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

    Goekkurt, E., Al-Batran, S-E., Hartmann, J. T., Mogck, U., Schuch, G., Kramer, M., Jaeger, E., Bokemeyer, C., Ehninger, G. & Stoehlmacher, J., 2009, In: J CLIN ONCOL. 27, 17, p. 2863-2873 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

    Schilling, G., Bruweleit, M., Harbeck, N., Thomssen, C., Becker, K., Hoffmann, R., Villena, C., Schütte, M., Hossfeld, D., Bokemeyer, C. & De Wit, M., 2009, In: INVEST NEW DRUG. 27, 2, p. 166-172 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

    Knödler, A., Schmidt, S. M., Bringmann, A., Weck, M. M., Brauer, K. M., Holderried, T. A. W., Heine, A-K., Grünebach, F. & Brossart, P., 2009, In: LEUKEMIA. 23, 3, p. 535-544 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

    Kröger, N., Badbaran, A., Lioznov, M., Schwartz, S., Zeschke, S., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Schilling, G., Zabelina, T., Bacher, U., Klyuchnikov, E., Shimoni, A., Nagler, A., Corradini, P., Fehse, B. & Zander, A. R., 2009, In: EXP HEMATOL. 37, 7, p. 791-798 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression.

    Rades, D., Lange, M., Veninga, T., Rudat, V., Bajrovic, A., Stalpers, L. J. A., Dunst, J. & Schild, S. E., 2009, In: INT J RADIAT ONCOL. 73, 1, p. 228-234 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case report

    Kobold, S., Merz, H., Tiemann, M., Mahuad, C., Bokemeyer, C., Koop, I. & Fiedler, W., 2009, In: RARE TUMORS. 1, 2, p. 173-175 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Pro-angiogenic properties of orosomucoid (ORM).

    Irmak, S., Oliveira-Ferrer, L., Singer, B. B., Ergün, S. & Tilki, D., 2009, In: EXP CELL RES. 315, 18, p. 3201-3209 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

    Bacher, U., Badbaran, A., Fehse, B., Zabelina, T., Zander, A. R. & Kröger, N., 2009, In: EXP HEMATOL. 37, 1, p. 135-142 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

    Tribius, S., Kronemann, S., Kilic, Y., Schroeder, U., Hakim, S., Schild, S. E. & Rades, D., 2009, In: STRAHLENTHER ONKOL. 185, 10, p. 675-681 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric, V. C., Labianca, R., Bodoky, G., Barone, C., Aranda, E., Nordlinger, B., Topham, C., Tabernero, J., André, T., Sobrero, A. F., Mini, E., Greil, R., Francesco, D. C., Collette, L., Cisar, L., Zhang, X., Khayat, D., Bokemeyer, C., Roth, A. D. & Cunningham, D., 2009, In: J CLIN ONCOL. 27, 19, p. 3117-3125 19.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D.

    Metzner, A., Precht, C., Fehse, B., Fiedler, W., Stocking, C., Günther, A., Mayr, G. W. & Jücker, M., 2009, In: GENE THER. 16, 4, p. 570-573 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. [Registries and clinical trials in geriatric oncology in Germany]

    Honecker, F. & Bokemeyer, C., 2009, In: ONKOLOGIE. 32, 3, p. 14-18 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Retroviral insertion site analysis in dominant haematopoietic clones.

    Kustikova, O. S., Modlich, U. & Fehse, B., 2009, In: Methods Mol Biol. 506, p. 373-390

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...68 69 70 71 72 73 74 75 ...87 Next